Adjunctive glucocorticoid therapy in patients with septic shock.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS: We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS: From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS: Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationA Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Cited by
Items 701–800 of 1,000
Kommareddy, A., Vagha, J. D., & Meshram, R. J. (2023) · Cureus · doi:10.7759/cureus.49870 · Cited by 5
“This trial investigated whether hydrocortisone could improve critical outcomes, including mortality rates and shock duration, among patients in this particular population [20].”
BackgroundVenkatesh, B., & Cohen, J. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00470-8 · Cited by 2
Self-citationChausse, J., Malekele, L., & Paruk, F. (2018) · Southern African Journal of Critical Care · doi:10.7196/sajcc.2018.v34i1.361 · Cited by 2
Evidenzbasierte, interdisziplinäre Behandlung der abdominellen Sepsis
Schmoch, T., Al‐Saeedi, M., Hecker, A., Richter, D., Brenner, T., Hackert, T., & Weigand, M. A. (2019) · Der Chirurg · doi:10.1007/s00104-019-0795-6 · Cited by 2
Freier, D., & Buttgereit, F. (2019) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-019-00686-1 · Cited by 2
Evolution not revolution: the future of the randomised controlled trial in intensive care research
Peake, S., Delaney, A. P., & French, C. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50338 · Cited by 2
Akutes pulmorenales Syndrom auf der Intensivstation
Enghard, P., Erley, C. M. M., & Schreiber, A. (2019) · Der Nephrologe · doi:10.1007/s11560-019-00373-x · Cited by 2
Relações da corticoterapia no tratamento do choque séptico
Neta, A. B. C. S., Chaves, A. C. H., Dias, L. R., Mascarenhas, I. R., Macêdo, I. M., Guizzetti, M. I. A., Lacerda, T. F., & Machado, L. C. D. S. (2020) · Brazilian Journal of Health Review · doi:10.34119/bjhrv3n1-101 · Cited by 3
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
Choong, C., Belger, M. A., Koch, A. E., Meyers, K. J., Marconi, V. C., Abedtash, H., Faries, D. E., & Krishnan, V. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02267-2 · Cited by 2
“Due to reported drug shortages of dexamethasone and hospital policies that may restrict its use in a subset of critically ill patients with COVID-19 [24], clinicians may be reluctant to use corticosteroids because of the conflicting evidence for steroids in other forms of acute respiratory distress syndrome [25, 26].”
BackgroundKuo, K.-C., Chen, C., Wang, C.-J., Wu, J.-C., Chung, H.-P., Chen, Y.-T., Tang, Y.-H., Chang, W.-K., Lin, C.-Y., & Wu, C. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02168-8 · Cited by 2
“The ADRENAL trial reported no difference in primary outcome (90-day mortality) between hydrocortisone and placebo groups, but a shorter median time to resolution of shock, discharge from the ICU, and cessation of mechanical ventilation [44].”
BackgroundArab, O. A., Ly, A., Amrouche, I., Andrei, S., & Mongardon, N. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.06.003 · Cited by 2
Hydrocortisone plus fludrocortisone: Taichi of risk hedge for improving adults with septic shock
Chen, W., Wang, Y., & Zhong, M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.18 · Cited by 1
“(2) did not favor hydrocortisone therapy alone in patients with septic shock undergoing mechanical ventilation.”
BackgroundZhao, Q., Xiao, J., & Liu, H. (2022) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000036 · Cited by 1
The metabolic and endocrine response to trauma
Krepska, A., Hastings, J., & Roodenburg, O. S. (2023) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2023.04.012 · Cited by 1
Inflammation, immunity and allergy
Sparks, R., & Nichol, A. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.05.010 · Cited by 1
Jiradechpitak, U., Tangsuwanaruk, T., Sitthiprawiat, P., & Wittayachamnankul, B. (2025) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2025.02.002 · Cited by 1
AlMubayedh, H. O., Almehizia, R., Salam, A., Alghunaim, R., Mohammed, O., Alrbiaan, A., & Al‐Qadheeb, N. S. (2025) · Critical Care Explorations · doi:10.1097/cce.0000000000001290 · Cited by 1
Emerging Paradigms in Sepsis Management: Critical Insights from Contemporary Clinical Trials
Sasidharan, S., & Dhillon, H. S. (2025) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_32_25 · Cited by 1
Yang, D., Jiang, C., & Xiao, Z. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108425 · Cited by 1
Current and emerging therapeutic options for refractory septic shock: A systematic review
Nácul, F. E., Bezerra, M. B., Gomes, B. C., Hohmann, F. B., Treml, R. E., Caldonazo, T. M. M., da Silva, A. A., Passos, R. D. H., de Oliveira, N. E., Bedretchuk, G. P., et al. (2025) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v14.i4.111164 · Cited by 1
Evaluation of Stress-Dose Steroid Weaning Strategies in Patients Following Septic Shock
Denninger, J. M., Toler, J. A., Skovran, S., & Westlake, E. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251385523 · Cited by 1
Harnessing native corticosteroid-binding globulin to treat life-threatening septic shock
Ramsay, S. D., Kilgariff, D. E., Young, B. J., Darveniza, L. C., Doig, R. O., Hollis, C. A., Hurtado, P. R., Plummer, M. P., Robins, E. G., Lee, J. H., et al. (2026) · Endocrinology · doi:10.1210/endocr/bqag002 · Cited by 1
A novel CD112-derived peptide targeting gut-primed neutrophils to attenuate deadly hepatic injury
Kato, T., Murao, A., Jha, A., Ma, G., Aziz, M., & Wang, P. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01426-3 · Cited by 1
“…corticosteroids are commonly used to blunt widespread inflammation and protect multiple organs (Cain and Cidlowski 2017; Annane et al. 2018; Venkatesh et al. 2018), their broad inhibition of cytokine pathways and suppression of neutrophil function can increase susceptibility to infection…”
Inhaled Angiopoietin‐Like 4 Antisense Oligonucleotide Therapy for Lung Injury and Fibrosis
Fan, H., Tan, Y., Zhang, J., Liu, X., Qu, J., Chua, D., Cheng, H. S., Kim, J. H. S., Liu, Y. X., Qin, C., et al. (2026) · Advanced Science · doi:10.1002/advs.202501909 · Cited by 2
Harb, H. (2026) · Information · doi:10.3390/info17050430 · Cited by 1
ARDS and corticosteroids: beyond COVID-19
Esperatti, M., Olmos, M., & Fuentes, N. A. (2026) · Pneumonia · doi:10.1186/s41479-026-00200-7 · Cited by 1
“Two used hydro‑ cortisone 50 mg every six hours plus fludrocortisone 50 μg daily for seven days and demonstrated significant mortality benefit [50–53].”
InfluentialNuclear receptors shape sepsis pathophysiology
Jelinek, M., Bosscher, K. D., Libert, C., & Vandewalle, J. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag017 · Cited by 1
Edwin, E., & Jayaprakash, N. (2026) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2026.06.002 · Cited by 2
Bayesian Thinking in the Intensive Care Unit: From Statistical Theory to Clinical Practice
Schultz, M. J., Nasa, P., Tripathy, S., Veenith, T., & Neto, A. S. (2026) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25229 · Cited by 1
Melo, P., Wendel‐Garcia, P. D., Léone, M., Khanna, A. K., Morales, S., Ospina-Tascón, G. A., Castro, R., Glenn Hernández, P., & Kattan, E. (2026) · Critical Care · doi:10.1186/s13054-026-06197-1 · Cited by 1
“…(Adjunctive Cor-ticosteroid Treatment in Critically Ill Patients with Septic Shock) showed shorter shock duration without mortality benefits [63], whereas the more unstable APROCCHSS (Activated Protein C and Corticosteroids for Human Septic Shock) cohort had reduced 90-day mortality with…”
Sepsis as CNS-governed metabolic triage
Yurtsever, B., & Demirkol, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1842915 · Cited by 1
“Another two trials, which found no mortality bene fi t, tested hydrocortisone alone (31, 32).”
Clinical Management of Endotoxemia: Corticosteroids
Boscolo, A., Sella, N., Pettenuzzo, T., & Navalesi, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-18591-5_8 · Cited by 1
A Genome-Wide Association Study of Serum Metabolite Profiles in Septic Shock Patients
Daubney, E. R., D’Urso, S., Cuéllar-Partida, G., Rajbhandari, D., Peach, E., de Guzman, E., McArthur, C. J., Rhodes, A., Meyer, J., Finfer, S. R., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001030 · Cited by 1
Self-citationChuang, C., Belfield, L. T., Krall, J., Gibbs, K. W., Liu, C., Purcell, L. D., Stapleton, R. D., Poynter, M. E., Toth, M. J., Quinn, M., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2025 · Cited by 1
Neumann, C., Leitner, M., Bloos, F., Lange, D., Bogatsch, H., Annane, D., Fleuriet, J., Briegel, J., Bauer, M. W., SepNet Critical Care Trials Group, et al. (2025) · Infection · doi:10.1007/s15010-025-02569-x · Cited by 1
“The administration of corticosteroids is one of the few immunomodulatory treatments for selected patients with septic shock [7] despite controversial results [8–13], side effects, and corticosteroid resistance [14].”
Comparative Effectiveness of Less vs. More Frequent Hydrocortisone Dosing in Septic Shock
Hao, A., Wu, T. D., Collins, K., Guffey, D., Kessinger, R., Vallabh, M., & Omranian, A. (2025) · Critical Care Explorations · doi:10.1097/cce.0000000000001316 · Cited by 1
Chang, W.-H., Hu, T.-Y., & Kuo, L. (2025) · Diseases · doi:10.3390/diseases13120382 · Cited by 1
“This observation is in line with recent real-world series [31,32].”
Impact of sex on outcomes in septic shock patients treated with hydrocortisone
Moustafa, H. A. M., Montasser, M., Ahmed, I., Mansy, A. E. A., & Habib, T. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-28014-5 · Cited by 1
“Because of their pleiotropic effects, corticosteroids are widely used as a concomitant treatment in sepsis for their anti-inflammatory, metabolic, and immune-suppressing actions 29,30 .”
Chalermwutanon, A., Saejaow, S., & Vattanavanit, V. (2026) · Acute and Critical Care · doi:10.4266/acc.000125 · Cited by 1
“Patients in our study appeared to be more severely affected than those in previous studies, as indicated by a mortality rate of 56.2% in patients with septic shock, compared to ≤50% in two recent major randomized trials of steroid use in septic shock [13,21].”
InfluentialXu, C., Ding, K., Zhou, X., Xu, Z., Chen, B., & Wang, H. (2026) · Science Progress · doi:10.1177/00368504261424390 · Cited by 1
“4,5 Previous studies have delineated several sepsis subphenotypes through genomics and transcriptomics approaches, revealing their signi fi cant implications for both therapeutic interventions and precision trial design.”
Ding, X., Chen, S., Zhu, L., Zheng, C., Mou, H., Cai, G., & Shen, Y. (2026) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2025.12.011 · Cited by 1
Practical Tips for Clinical Stabilization in Septic Shock
Khanna, A. K., & Wieruszewski, P. M. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007076 · Cited by 1
Glucocorticoids in pregnancy: a master-switch for fetal maturation
Tan, Y., Stark, M. J., Clifton, V. L., Wiese, M. D., Morrison, J. L., & Gatford, K. L. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag015 · Cited by 1
Ahn, S., Ahn, C., Hwang, S. Y., Kim, S.-M., Park, J.-H., Kim, W. Y., Park, S.-J., Choi, S.-H., Kwon, W. Y., Kong, T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-56521-6 · Cited by 2
“Current recommendations largely reflect the inclusion criteria of major ICU-based randomized controlled trials, which defined an ongoing vasopressor requirement as a norepinephrine or epinephrine dose ≥ 0.25 µg/kg/min for at least 4 h to maintain target mean arterial pressure 2,3,10,11,18 .”
InfluentialPost-Sepsis Syndrome after Critical Illness
Wozniak, H., Balzani, E., Santangelo, E., & Herridge, M. S. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2026.05.011 · Cited by 1
The Postcardiac Arrest Inflammatory Response: Mechanisms and Therapeutic Targets
Batchelor, R., Stub, D. A., Donner, D. G., Burrell, A. J. C., Nehme, Z., Bloom, J. E., & Kaye, D. M. (2026) · Circulation · doi:10.1161/circulationaha.126.080096 · Cited by 1
Roquilly, A., & Asehnoune, K. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.02.004 · Cited by 2
“administré chez des patients moins graves (mortalité de 20% dans le groupe contrôle), aucun effet délétère n’a été observé alors que le bénéfice hémodynamique (sevrage des amines vasopressives) reste constant [38,39].”
BackgroundCardiac Complications in Neurocritical Care Patients
Kim, J. A., & Izzy, S. (2020) · Current clinical neurology · doi:10.1007/978-3-030-36548-6_4 · Cited by 1
Update der Surviving-Sepsis-Campaign-Leitlinie 2021 – Was ist neu?
Briegel, J., & Möhnle, P. (2022) · Der Anaesthesist · doi:10.1007/s00101-022-01087-x · Cited by 1
Goel, N. N., Chen, J., Roberts, R. J., Sevransky, J., Gong, M. N., Mathews, K. S., & VOLUME-CHASERS Study Group and Society of Critical Care Medicine Discovery Network (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221081102 · Cited by 1
Pfeiffer, S., & Wong, H. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-53363-2_17 · Cited by 2
Pérez, G. F. F., Pulgarín, G. A. Z., & Cevallos, J. F. N. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n1-341 · Cited by 2
Acute Respiratory Failure and Ventilator Management Afloat
Grasso, I., & Collins, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-21893-4_21 · Cited by 1
Advancing Sedation Strategies to Improve Clinical Outcomes in Ventilated Critically Ill Patients
Shehabi, Y., Al‐Bassam, W., & Antognini, D. (2023) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-031-23005-9_17 · Cited by 1
Chinaeke, E. E., Yunusa, I. U., Love, B. L., Magagnoli, J., & Reeder, C. E. (2023) · American Journal of Pharmacotherapy and Pharmaceutical Sciences · doi:10.25259/ajpps_2023_005 · Cited by 1
Role of corticosteroids in the treatment of critically ill sepsis patients: a meta-analysis review
Song, Y., Hao, J., & Liu, Y. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01426-3 · Cited by 1
“Finally, nine articles were included for meta-analysis (Torres et al. 2015; Annane et al. 2002, 2018; Venkatesh et al. 2018; Arabi et al. 2010; Gordon et al. 2014; Yildiz et al. 2002; Lv et al. 2017; Menon et al. 2017).”
Steroids in acute respiratory distress syndrome: A panacea or still a puzzle?
Sinha, S., Patnaik, R., & Behera, S. K. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i2.91225 · Cited by 2
Was ist gesichert in der Therapie der Sepsis? Ein Update
Hillebrand, U., Rex, N., Seeliger, B., Stahl, K., & Schenk, H. J. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01794-0 · Cited by 1
Donaldson, L., Hammond, N. E., Smyth, K. L., Agarwal, S., Taylor, S., Bompoint, S., Coombes, J., Bennett‐Brook, K., Bellomo, R., Myburgh, J., et al. (2024) · Nephrology · doi:10.1111/nep.14405 · Cited by 1
“16 The only ADRENAL study site, which recruited large numbers of Aboriginal or Torres Strait Islander people, was Royal Darwin Hospital, a referral hospital in the tropical north of Australia.”
Self-citationEndocrine Issues in Neurocritical Care
Long, M. T., Leiendecker, E., Dollerschell, J. T., Tokarcyzk, A., & Coursin, D. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-62220-5_35 · Cited by 1
Is fludrocortisone the missing piece in septic shock? A closer look. Author's reply
Walsham, J., & Venkatesh, B. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07692-1 · Cited by 1
Self-citationGupta, N. R., Tirlangi, P. K., Ravindra, P., Bhat, R., Gupta, M., Boodman, C., Rashid, A., & Mukhopadhyay, C. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100303 · Cited by 1
Systematic Review on Impacts of Vitamin C, Thiamin, and Hydrocortisone in Sepsis
Khan, A., & Tidman, M. M. (2025) · Journal of Health and Medical Sciences · doi:10.31014/aior.1994.08.01.335 · Cited by 1
Delirium in the ICU: Pathophysiology, Diagnosis and Management
Glassford, N. J., Olver, R., & Shehabi, Y. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_19 · Cited by 1
Gruccio, P., Girard, W. S., Badipour, A. D., Kakande, R., Adejayan, V., Zulfiqar, M., Ndyomugabe, M., Ojuman, P., Heysell, S. K., Null, M. D., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004429 · Cited by 1
Takano, H., Kanda, N., Ohbe, H., Yoshida, M., & Nakamura, K. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251353723 · Cited by 1
“12,13 Previous studies reported negative outcomes concerning improvements in short-term mortality.”
Corticosteroid Treatment in Septic Shock
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2694-4823 · Cited by 1
Molendijk, A. J., & Koenderman, L. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag068 · Cited by 1
Scoring systems for sepsis: which purposes can they serve?
Brun‐Buisson, C. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.07.002 · Cited by 1
Sepsis-Update: evidenzbasierte Therapie
Märtin, L., Bickenbach, J., & Marx, G. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0625-5521 · Cited by 1
“[44] Venkatesh B, Finfer S, Cohen J et al.”
BackgroundNew sepsis cocktail – thanks for the new marik protocol
Sewify, K., & Alshaer, A. (2018) · Journal of Anesthesia & Critical Care Open Access · doi:10.15406/jaccoa.2018.10.00362 · Cited by 1
Sepsis and Septic Shock: A Review of Definitions, Pathogenesis, and Treatment
Butler, T., & Levin, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17148-3_22 · Cited by 2
Critical Illness Related Corticosteroid Insufficiency (CIRCI)
Khosla, A. J., & Ahasic, A. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_55 · Cited by 1
Adrenal Insufficiency in Severe Falciparum Malaria: Its Outcome and Prediction by Discriminant Score
Mohapatra, M. K., Bariha, P. K., & Mohapatra, A. (2019) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2019.6.9.48 · Cited by 1
Al-Shimemeri, A. A., Alenezi, F. Z., Alyamani, L., Alsumari, O., Alsulaiman, F. A., Basham, K., & Alnafisah, F. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_440_20 · Cited by 1
Steroide in der Infektionsmedizin
Spinner, C. D., Barton, J., Biever, P. M., Klein, M., Rieg, S., Schneider, J., Thoden, J., Wagner, D., & Kern, W. V. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1302-3530 · Cited by 1
“Die beiden jüngsten größeren klinischen Studien zur Thematik Steroide und septischer Schock stammen aus dem Jahre 2018: die australischneuseeländische ADRENAL-Studie und die französische APROCCHSS-Studie [6, 7].”
BackgroundLonghini, F., Garofalo, E., & Bruni, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-71917-3_10 · Cited by 1
Swain, K., Nanda, S., Jayasingh, S. C., Routray, S. S., Swain, A., & Sahoo, P. (2021) · International Journal of Recent Surgical and Medical Sciences · doi:10.1055/s-0041-1731916 · Cited by 1
Arai, T., Mori, Y., Yoshizaki, S., Andõ, R., Natori, S., Morishita, S., Otani, M., 沼田, 篤., & Osanai, H. (2021) · Oxford Medical Case Reports · doi:10.1093/omcr/omab109 · Cited by 1
“An adjunctive low-dose steroid has been reported to significantly shorten the time to recover from septic shock [6].”
BackgroundThe metabolic and endocrine response to trauma
Krepska, A., Hastings, J., & Roodenburg, O. S. (2020) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2020.04.011 · Cited by 1
The Endocrine Response to Stress
Henley, D., Upton, T. J., & Lightman, S. L. (2022) · doi:10.1093/med/9780198870197.003.0203 · Cited by 1
Magalhães, T. B. S., Mendonça, A. J., Zorzo, C., Morgado, T. O., Corrêa, S. H. R., Palermo, A. L. P., Nardes, E. R. D. S., & Costa, K. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i2.24480 · Cited by 1
Pekkarinen, P. T., Skrifvars, M. B., & Varón, J. (2019) · Resuscitation · doi:10.1016/j.resuscitation.2019.04.032 · Cited by 1
Ich glaube nur der Statistik, die ich selbst gefälscht habe
Leistner, R. (2019) · Krankenhaushygiene up2date · doi:10.1055/a-0975-1110 · Cited by 1
“Die Publikationen stellen die Ergebnisse zweier randomisierter, placebokontrollierter Studien (RCT) mit insgesamt knapp 5000 eingeschlossenen Patienten dar [1, 2].”
BackgroundSweeney, T. E., & Wong, H. R. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06504-0 · Cited by 1
“The largest study of these, ADRENAL (N = 3658), showed no mortality benefit with corticosteroids, but shorter time in shock and on mechanical ventilation [3].”
BackgroundSidebotham, D. A. (2021) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/202153239 · Cited by 1
Monotherapy or Combination Therapy for Septic Shock? A Debate on Steroids
Tsolaki, V., & Siempos, I. Ι. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0175ed · Cited by 1
Rodhouse, C. E., Wang, D., Tang, H., Polcz, V. E., Hernández-Ríos, M., Yu, X., Balzano‐Nogueira, L., Rincon, J. C., Charles, A. M., Fujishima, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.06.680736 · Cited by 1
Management of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_53
ADRENAL und die Kontroverse zu Hydrokortison im septischen Schock
Briegel, J. (2018) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-018-0410-5
Niedrig dosiertes Hydrokortison ohne Vorteile
Medizin, S. (2018) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-018-2666-y
Misset, B. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.08.018
Nuevas recomendaciones sobre el uso de corticoides en el paciente crítico
Gil, I. D. L. C., Revuelta, E. C., & García-Álvarez, R. (2018) · Revista Electrónica AnestesiaR · doi:10.30445/rear.v10i11.649
Corticosteroid Therapy for Septic Shock and Pediatric ARDS
Jacobs, L., Wong, H. R., & Menon, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-96499-7_16
Adrenal Emergencies in Critically Ill Cancer Patients
Richard, R. P., Grishaw, J. A., & Enfield, K. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-74698-2_81-1
Modern Critical Care Endocrinology and Its Impact on Critical Care Medicine
Bellomo, R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.01.001
Self-citation2018 Year in Review in Critical Care
Arabi, Y. M., Gouda, A., & Ali, Y. (2019) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_72_19
“The recent ADRENAL trial[5] compared hydrocortisone 200 mg/day, given as continuous infusion for 7 days or until intensive care unit (ICU) discharge to placebo.”
Self-citationMcCague, A., Haberlach, M., & Cedar, C. (2019) · Journal of Emergencies Trauma and Shock · doi:10.4103/jets.jets_85_18
“Similarly, a retrospective review of the University of Virginia Trauma Registry and the ADRENAL trial showed no difference in mortality in patients who received steroids compared to placebo.[10,11] However, in the ADRENAL trial, ventilated patients on pressor support who received hydrocortisone required ventilator sup…”
Annane, D., Bollaert, P., Demoule, A., Mira, J. P., Monnet, X., Teboul, J., & Vieillard‐Baron, A. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0112
Ostro, B., King, A., Branditz, L. D., Martín, D. E. A., Bachmann, D., Panchal, A. R., & Barrie, M. G. (2019) · Journal of Education and Teaching in Emergency Medicine · doi:10.5070/m543044551
Metadata
- Authors
- Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., & Myburgh, J.
- Affiliations
- The University of Sydney (AU)
- From the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hospital (S.F.), Sydney, the Princess Alexandra Hospital (B.V., C.J.) and Royal Brisbane and Women’s Hospital (J.C.), University of Queensland, and the Wesley Hospital (B.V., J.C.), Brisbane, Austin Hospital (R.B.), the...
- University of Copenhagen (DK)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 797-808
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2784412824
- Cited by
- 1,037
- References
- 40
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 90 · 2023: 106 · 2022: 110 · 2021: 121 · 2020: 149 · 2019: 135 · 2018: 91
- FWCI
- 96.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Repository (Kingston University London) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- National Health and Medical Research Council (1004108, 1124926)
- Health Research Council of New Zealand (12/206)
- National Institute of Health Research, United Kingdom
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, mortality, mechanical ventilation, shock resolution, blood transfusion, intensive care unit, sepsis treatment, subgroup analysis, mechanical ventilation duration, vasopressor requirement, glycemic control
- MeSH terms
- Aged, Anti-Inflammatory Agents, Double-Blind Method, Female, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Rate, Fungemia, Bacteremia, Treatment Outcome, Chemotherapy, Adjuvant, Renal Replacement Therapy, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.